Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30,812Revenue (TTM) $M4,957Net Margin (%)17.3Altman Z-Score4.9
Enterprise Value $M34,677EPS (TTM) $1.7Operating Margin %28.6Piotroski F-Score6
P/E(ttm)36.5Beneish M-Score-2.4Pre-tax Margin (%)24.9Higher ROA y-yY
Price/Book19.210-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsN
Price/Sales6.35-y EBITDA Growth Rate %12.9Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow55.0y-y EBITDA Growth Rate %66.2ROA % (ttm)11.3Higher Current Ratio y-yN
Dividend Yield %0.7PEG2.8ROE % (ttm)59.4Less Shares Outstanding y-yY
Payout Ratio %23.0Shares Outstanding M491ROIC % (ttm)18.6Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ZTS is held by these investors:



ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Knupp Catherine A.Executive Vice President 2017-05-12Sell5,785$60.164.36view
PECK KRISTIN CExecutive Vice President 2016-11-22Sell10,092$49.5526.7view
Lagano RoxanneExecutive Vice President 2016-11-08Sell9,797$50.4324.49view
MCCALLISTER MICHAEL BDirector 2016-09-06Buy2,000$51.3422.28view
Fenton AndrewExecutive Vice President 2016-09-02Sell13,870$51.2522.5view
Chen Heidi C.Executive Vice President 2016-09-01Sell32,097$50.9823.15view
Pershing Square Capital ManageDirector 2016-05-09Sell16,850,000$46.5534.87view
Pershing Square Capital ManageDirector 2015-07-01Sell1,540,713$48.2230.19view
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.35100.26view
Lagano RoxanneExecutive Vice President 2013-02-06Buy2,000$26141.46view

Quarterly/Annual Reports about ZTS:

News about ZTS:

Articles On GuruFocus.com
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 
Charles D. Christy Named Chief Financial Officer Jun 23 2017 
Harwood Feffer LLP Announces Investigation of CardConnect Corp. Jun 23 2017 
eCobalt Provides Feasibility Study Update on the Idaho Cobalt Project Jun 23 2017 
Tanger Outlet Centers Schedules Second Quarter 2017 Earnings Release and Conference Call Jun 23 2017 
Cortelco Systems Puerto Rico, Inc. Board of Directors Authorizes Dividend Jun 23 2017 
Take-Two Is Set to Soar Higher Jun 23 2017 

More From Other Websites
Cramer's lightning round: Don't go down the food chain in this space Jun 22 2017
ETFs with exposure to Zoetis, Inc. : June 20, 2017 Jun 20 2017
Zoetis, Inc. :ZTS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Jun 19 2017
Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial Jun 15 2017
Zoetis, Inc. : ZTS-US: Dividend Analysis : June 15th, 2017 (record date) : By the numbers : June 15,... Jun 15 2017
Looking For A Better Entry Point, BMO Downgrades Zoetis Shares Jun 13 2017
Zoetis Stock Is Sizzling Hot -- Here's What Could Make It Cool Down Jun 11 2017
Adamas Provides Positive Long-term Data on Parkinson's Drug Jun 09 2017
Zoetis (ZTS) Up 6.4% Since Earnings Report: Can It Continue? Jun 08 2017
Jazz Pharma Sleep Disorder Candidate Positive in Phase III Jun 07 2017
Celgene and Agios Announce Data on Idhifa for Leukemia Jun 07 2017
Zoetis Just Hit an All-Time High: Here's Why the Stock Should Go Higher Jun 03 2017
Celgene & Acceleron Complete Enrollment on Thalassemia Drug Jun 02 2017
Zoetis to Participate in the William Blair Growth Stock Conference Jun 01 2017
Roche (RHHBY) Presents Positive Data on IPF Drug Esbriet May 26 2017
Zoetis to Participate in the Stifel 2017 Dental and Veterinary Conference May 25 2017
Horizon (HZNP) Sells European Rights for Procysbi & Quinsair May 25 2017
Celgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint May 23 2017
Can These 3 High-Flying Healthcare Stocks Reach the Clouds? May 23 2017
Adamas Epilepsy Drug Shows Positive Result in Phase Ia Study May 23 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}